3
Announcements
Trials
Browse
Landscape
Status
Temporarily not available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Pancreatic Neoplasms
13
Neoplasm Metastasis
10
Neoplasms
8
Lung Neoplasms
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Melanoma
4
Squamous Cell Carcinoma of Head and Neck
3
Endometrial Neoplasms
3
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Solid Tumor
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic cancer, adult
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Diseases
1
Pancreatic Cancer Non-resectable
1
Pancreas Adenocarcinoma
1
Interventions
spartalizumab
1
Taxes
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Locally Advanced Pancreatic Adenocarcinoma
×
Taxes
×
Clear all
NCT07319910
2026-01-06
PANOVA-3CA
NovoCure Ltd.
Temporarily not available